rs765091519

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 2P and 11B. PM2BP4_ModerateBP6_Very_StrongBP7

The NM_000719.7(CACNA1C):​c.4068C>A​(p.Ser1356Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. S1356S) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

CACNA1C
NM_000719.7 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.579

Publications

1 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.26).
BP6
Variant 12-2651762-C-A is Benign according to our data. Variant chr12-2651762-C-A is described in ClinVar as Likely_benign. ClinVar VariationId is 798433.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.579 with no splicing effect.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.4068C>A p.Ser1356Ser synonymous_variant Exon 32 of 47 ENST00000399655.6 NP_000710.5
CACNA1CNM_001167623.2 linkc.4068C>A p.Ser1356Ser synonymous_variant Exon 32 of 47 ENST00000399603.6 NP_001161095.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.4068C>A p.Ser1356Ser synonymous_variant Exon 32 of 47 5 NM_001167623.2 ENSP00000382512.1
CACNA1CENST00000399655.6 linkc.4068C>A p.Ser1356Ser synonymous_variant Exon 32 of 47 1 NM_000719.7 ENSP00000382563.1
CACNA1CENST00000682544.1 linkc.4302C>A p.Ser1434Ser synonymous_variant Exon 34 of 50 ENSP00000507184.1
CACNA1CENST00000406454.8 linkc.4068C>A p.Ser1356Ser synonymous_variant Exon 32 of 48 5 ENSP00000385896.3
CACNA1CENST00000399634.6 linkc.4035C>A p.Ser1345Ser synonymous_variant Exon 31 of 47 5 ENSP00000382542.2
CACNA1CENST00000683824.1 linkc.4233C>A p.Ser1411Ser synonymous_variant Exon 33 of 48 ENSP00000507867.1
CACNA1CENST00000347598.9 linkc.4212C>A p.Ser1404Ser synonymous_variant Exon 34 of 49 1 ENSP00000266376.6
CACNA1CENST00000344100.7 linkc.4134C>A p.Ser1378Ser synonymous_variant Exon 32 of 47 1 ENSP00000341092.3
CACNA1CENST00000327702.12 linkc.4068C>A p.Ser1356Ser synonymous_variant Exon 32 of 48 1 ENSP00000329877.7
CACNA1CENST00000399617.6 linkc.4068C>A p.Ser1356Ser synonymous_variant Exon 32 of 48 5 ENSP00000382526.1
CACNA1CENST00000682462.1 linkc.4158C>A p.Ser1386Ser synonymous_variant Exon 32 of 47 ENSP00000507105.1
CACNA1CENST00000683781.1 linkc.4158C>A p.Ser1386Ser synonymous_variant Exon 32 of 47 ENSP00000507434.1
CACNA1CENST00000683840.1 linkc.4158C>A p.Ser1386Ser synonymous_variant Exon 32 of 47 ENSP00000507612.1
CACNA1CENST00000683956.1 linkc.4158C>A p.Ser1386Ser synonymous_variant Exon 32 of 47 ENSP00000506882.1
CACNA1CENST00000399638.5 linkc.4152C>A p.Ser1384Ser synonymous_variant Exon 33 of 48 1 ENSP00000382547.1
CACNA1CENST00000335762.10 linkc.4143C>A p.Ser1381Ser synonymous_variant Exon 33 of 48 5 ENSP00000336982.5
CACNA1CENST00000399606.5 linkc.4128C>A p.Ser1376Ser synonymous_variant Exon 33 of 48 1 ENSP00000382515.1
CACNA1CENST00000399621.5 linkc.4068C>A p.Ser1356Ser synonymous_variant Exon 32 of 47 1 ENSP00000382530.1
CACNA1CENST00000399637.5 linkc.4068C>A p.Ser1356Ser synonymous_variant Exon 32 of 47 1 ENSP00000382546.1
CACNA1CENST00000402845.7 linkc.4068C>A p.Ser1356Ser synonymous_variant Exon 32 of 47 1 ENSP00000385724.3
CACNA1CENST00000399629.5 linkc.4119C>A p.Ser1373Ser synonymous_variant Exon 32 of 47 1 ENSP00000382537.1
CACNA1CENST00000682336.1 linkc.4110C>A p.Ser1370Ser synonymous_variant Exon 32 of 47 ENSP00000507898.1
CACNA1CENST00000399591.5 linkc.4035C>A p.Ser1345Ser synonymous_variant Exon 31 of 46 1 ENSP00000382500.1
CACNA1CENST00000399595.5 linkc.4035C>A p.Ser1345Ser synonymous_variant Exon 31 of 46 1 ENSP00000382504.1
CACNA1CENST00000399649.5 linkc.4029C>A p.Ser1343Ser synonymous_variant Exon 31 of 46 1 ENSP00000382557.1
CACNA1CENST00000399597.5 linkc.4068C>A p.Ser1356Ser synonymous_variant Exon 32 of 47 1 ENSP00000382506.1
CACNA1CENST00000399601.5 linkc.4068C>A p.Ser1356Ser synonymous_variant Exon 32 of 47 1 ENSP00000382510.1
CACNA1CENST00000399641.6 linkc.4068C>A p.Ser1356Ser synonymous_variant Exon 32 of 47 1 ENSP00000382549.1
CACNA1CENST00000399644.5 linkc.4068C>A p.Ser1356Ser synonymous_variant Exon 32 of 47 1 ENSP00000382552.1
CACNA1CENST00000682835.1 linkc.4068C>A p.Ser1356Ser synonymous_variant Exon 32 of 47 ENSP00000507282.1
CACNA1CENST00000683482.1 linkc.4059C>A p.Ser1353Ser synonymous_variant Exon 32 of 47 ENSP00000507169.1
CACNA1CENST00000682686.1 linkc.4035C>A p.Ser1345Ser synonymous_variant Exon 31 of 46 ENSP00000507309.1

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1453946
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
722026
African (AFR)
AF:
0.00
AC:
0
AN:
33384
American (AMR)
AF:
0.00
AC:
0
AN:
44484
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25794
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39556
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85522
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53060
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5712
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1106378
Other (OTH)
AF:
0.00
AC:
0
AN:
60056
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Long QT syndrome Benign:1
Nov 30, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Nov 11, 2019
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.26
CADD
Benign
11
DANN
Benign
0.75
PhyloP100
0.58

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs765091519; hg19: chr12-2760928; API